LGM Pharma

LGM Pharma is a pharmaceutical services company supporting drug development and manufacturing from early research through commercialization. It supplies active pharmaceutical ingredients (APIs), helping customers source, import, and obtain ingredients in custom quantities and specialized chemistries. Its API services include product sourcing, strategic sourcing, logistics, regulatory support, and manufacturer management, backed by a network of prequalified cGMP manufacturers.

The company also provides contract development and manufacturing organization (CDMO) services for a range of dosage forms, including solid-dose delivery systems, liquids and suspensions, semi-solids, and suppositories. Services span formulation development, commercial scale-up, and access to manufacturing facilities and equipment. LGM Pharma supports regulatory planning and drug-development pathways, including 505(b)(2) projects and ANDAs, with in-house regulatory expertise.

Its analytical services include method development, testing, and stability studies for APIs and drug products, with offerings for compounders and manufacturers. Through these services, LGM Pharma aims to help clients manage supply-chain risks, meet quality expectations, and advance products toward market.